Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 13.25
+0.25 (1.92%)
Oct 20, 2026, 1:47 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.78 billion as of October 20, 2026. It is the 19,681st most valuable company in the world and the 854th biggest in Taiwan. Its market cap has decreased by 18.36% in one year.
Market Cap
7.78B
Enterprise Value
4.58B
Revenue
n/a
Global Rank
Country Rank
#854 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.78B, a decrease of -66.04%. That is a compound annual growth rate of -28.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 7.78B | -12.88% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 9.43B |
| Locus Cell | 8.45B |
| Tanvex BioPharma | 8.24B |
| PharmaEngine | 8.13B |
| Adimmune | 7.50B |
| Polaris Group | 7.21B |
| OBI Pharma | 6.92B |
| Savior Lifetec | 6.88B |